Preparing CAR-T therapy market access with J&J

Preparing CAR-T therapy market access

In this project for a global pharma company, Healthskouts explored opportunities for the global launch readiness team preparing CAR-T therapy market access.

 CAR-T is a novel type of treatment in which a patient’s T immune cells are changed in the laboratory so they will attack cancer cells. T cells are taken from a patient’s blood. Then the gene for a special receptor that binds to a certain protein on the patient’s cancer cells is added to the T cells in the laboratory. The special receptor is called a chimeric antigen receptor (CAR). Large numbers of the CAR-T cells are grown in the laboratory and given to the patient by infusion. This comes with a number of supply chain challenges. 

Applying our Delight Thinking methodology to the entire product & patient journey, we:              

  • painted the art of the possible (with respect to mindset, infrastructure, …)
  • introduced a can-do mentality based on rethinking common assumptions, including inspiration from other industries (“this is how Disney, Amazon, … would have solved this”)
  • provided fresh inside in who the patient / end-user really is
  • showed how 3rd parties, beyond the  paying customer, could impact access to market for the better – and how to let them shine (e.g. supply chain, hospital)

Read more Healthskouts Cases

Scientific microbiome probiotics research using mixed reality technologies

Danone exhibit

Danone has entrusted us to turn their scientific microbiome & probiotics research into an exhibit in Paris showing compelling stories using mixed reality technologies (VR,

Read More »
Patient engagement companion App. Drug response patient experience


AI-driven pharmacy patient companion App We built a patient engagement companion App to follow-up drug response and experience in the real world / in the patient

Read More »